Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
1,621,226
-
Shares change
-
+481,372
-
Total reported value, excl. options
-
$13,179,000
-
Value change
-
+$3,912,448
-
Number of buys
-
5
-
Number of sells
-
-9
-
Price
-
$8.13
Significant Holders of IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) as of Q2 2015
17 filings reported holding IMMY - IMPRIMIS PHARMACEUTICALS INC - COM NEW as of Q2 2015.
IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,621,226 shares
.
Largest 10 shareholders include Opaleye Management Inc. (1,205,000 shares), Granite Investment Partners, LLC (129,627 shares), VANGUARD GROUP INC (89,966 shares), BANK OF AMERICA CORP /DE/ (64,699 shares), REGIONS FINANCIAL CORP (30,500 shares), MARATHON CAPITAL MANAGEMENT (25,000 shares), Granite Point Capital Management, L.P. (22,673 shares), BlackRock Fund Advisors (20,474 shares), GOLDMAN SACHS GROUP INC (14,306 shares), and RENAISSANCE TECHNOLOGIES LLC (11,000 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.